Product catalog antigen listed by alphabetic starting with L
| Items 1 to 100 of 496 total | 5 Page(s): |
Protein
| Catalog No. | Species | Presentation | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| PA1219 | L-Asparaginase antigen | ||||||
| Human | Purified | - | E. coli | 500 U / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1219X | L-Asparaginase antigen | ||||||
| Human | Purified | - | E. coli | 2500 U / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1219XC | L-Asparaginase antigen | ||||||
| Human | Purified | - | E. coli | 10000 U / ask | |||
| Acris Antibodies GmbH | |||||||
| H00080150-P01-10 | L-asparaginase / ASRGL1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00080150-P01-25 | L-asparaginase / ASRGL1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00080150-Q01-10 | L-asparaginase / ASRGL1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00080150-Q01-25 | L-asparaginase / ASRGL1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026013-P01-02 | L3MBTL antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026013-P01-10 | L3MBTL antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026013-P01-25 | L3MBTL antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00083746-Q01-10 | L3MBTL2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00083746-Q01-25 | L3MBTL2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00091133-P01-10 | L3MBTL4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00091133-P01-25 | L3MBTL4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA1330 | LA / SS-B antigen | ||||||
| Human | Purified | >90% | E. coli | 0.1 mg / US$ 345 | |||
| Acris Antibodies GmbH | |||||||
| PA1330X | LA / SS-B antigen | ||||||
| Human | Purified | >90% | E. coli | 0.5 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| PA1330XC | LA / SS-B antigen | ||||||
| Human | Purified | >90% | E. coli | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| BA383A | Lactate Dehydrogenase (LDH) antigen | ||||||
| Human | 209 U/mg | Heart | 50 U / US$ 285 | ||||
| Acris Antibodies GmbH | |||||||
| BA383P | Lactate Dehydrogenase (LDH) antigen | ||||||
| Human | Purified | 209 U/mg | Heart | 25 U / US$ 285 | |||
| Acris Antibodies GmbH | |||||||
| BA383 | Lactate Dehydrogenase 5 (LDH5) antigen | ||||||
| Human | >50U/mg | Skeletal muscle | 50 U / US$ 435 | ||||
| Acris Antibodies GmbH | |||||||
| AR00108PU-N | Lactate Dehydrogenase Isoenzyme 1 (LDH1) antigen | ||||||
| Human | Amm.Sulf.Susp. | Erythrocytes | 100 U / US$ 325 | ||||
| Acris Antibodies GmbH | |||||||
| AR00109PU-N | Lactate Dehydrogenase Isoenzyme 2 (LDH2) antigen | ||||||
| Human | Amm.Sulf.Susp. | Erythrocytes | 100 U / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| AR00110PU-N | Lactate Dehydrogenase Isoenzyme 3 (LDH3) antigen | ||||||
| Human | Amm.Sulf.Susp. | Erythrocytes | 100 U / US$ 405 | ||||
| Acris Antibodies GmbH | |||||||
| AR00111PU-N | Lactate Dehydrogenase Isoenzyme 4 (LDH4) antigen | ||||||
| Human | Amm.Sulf.Susp. | Liver | 100 U / US$ 455 | ||||
| Acris Antibodies GmbH | |||||||
| AR00112PU-N | Lactate Dehydrogenase Isoenzyme 5 (LDH5) antigen | ||||||
| Human | Amm.Sulf.Susp. | Liver | 100 U / US$ 195 | ||||
| Acris Antibodies GmbH | |||||||
| AR00113PU-N | Lactoferrin, Apo Form antigen | ||||||
| Human | Purified | Milk | 1 mg / US$ 405 | ||||
| Acris Antibodies GmbH | |||||||
| H00007957-Q01-10 | Laforin / EPM2A antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007957-Q01-25 | Laforin / EPM2A antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA244 | LAG-1 (CCL4L1) antigen | ||||||
| Human | >97% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA244X | LAG-1 (CCL4L1) antigen | ||||||
| Human | >97% | E. coli | 20 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| H00003906-Q01-10 | LALBA antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003906-Q01-25 | LALBA antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003908-Q01-10 | LAMA2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003908-Q01-25 | LAMA2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003909-Q01-10 | LAMA3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003909-Q01-25 | LAMA3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003910-P01-10 | LAMA4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003910-P01-25 | LAMA4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003914-Q01-10 | LAMB3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003914-Q01-25 | LAMB3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| BA353 | Lambda light chain antigen | ||||||
| Human | >95% | Myeloma | 5 mg / US$ 345 | ||||
| Acris Antibodies GmbH | |||||||
| P164-1 | Lambda light chain antigen | ||||||
| Human | >96% | Urine | 1 mg / ask | ||||
| Scipac Ltd. | |||||||
| P164-2 | Lambda light chain antigen | ||||||
| Human | Purified | >40% | Urine | 1 mg / ask | |||
| Scipac Ltd. | |||||||
| H00003915-P01-10 | LAMC1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003915-P01-25 | LAMC1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003918-Q01-10 | LAMC2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003918-Q01-25 | LAMC2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| BA390 | Laminin antigen | ||||||
| Human | >95% | Placenta | 0.1 mg / US$ 705 | ||||
| Acris Antibodies GmbH | |||||||
| BA391 | Laminin antigen | ||||||
| Mouse | >95% | Sarcoma | 1 mg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| H00010314-Q01-10 | LANCL1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010314-Q01-25 | LANCL1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051056-Q01-10 | LAP3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051056-Q01-25 | LAP3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055353-P01-10 | LAPTM4B antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055353-P01-25 | LAPTM4B antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00023395-Q01-10 | LARS2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00023395-Q01-25 | LARS2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003927-P01-10 | LASP1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003927-P01-25 | LASP1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00029956-P01-10 | LASS2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00029956-P01-25 | LASS2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00204219-Q01-10 | LASS3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00204219-Q01-25 | LASS3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00079603-Q01-10 | LASS4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00079603-Q01-25 | LASS4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00253782-Q01-10 | LASS6 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00253782-Q01-25 | LASS6 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00027040-P01-10 | LAT antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00027040-P01-25 | LAT antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| 10-288-22348F | Latexin antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22348F-50 | Latexin antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| H00009113-Q01-10 | LATS1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009113-Q01-25 | LATS1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003929-P01-10 | LBP antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003929-P01-25 | LBP antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003931-Q01-10 | LCAT antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003931-Q01-25 | LCAT antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00057189-P01-10 | LCHN antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00057189-P01-25 | LCHN antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003932-P01-10 | Lck antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003932-P01-25 | Lck antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003932-Q01-10 | Lck antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003932-Q01-25 | Lck antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| GTX25220 | Lck peptide-phospho S158 (phospho and non-phospho pair) antigen | ||||||
| 1 packs / --- | |||||||
| GeneTex Inc. | |||||||
| GTX25219 | Lck peptide-phospho Y192 (phospho and non-phospho pair) antigen | ||||||
| 1 packs / --- | |||||||
| GeneTex Inc. | |||||||
| GTX25217 | Lck peptide-phospho Y505 (phospho and non - phospho pair) antigen | ||||||
| 1 kit / --- | |||||||
| GeneTex Inc. | |||||||
| H00003933-Q01-10 | LCN1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003933-Q01-25 | LCN1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003934-P01-10 | LCN2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003934-P01-25 | LCN2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00064129-P01-10 | LCN7 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00064129-P01-25 | LCN7 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003938-Q01-10 | LCT antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003938-Q01-25 | LCT antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA203 | LD-78 beta antigen | ||||||
| Human | >98% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA203X | LD-78 beta antigen | ||||||
| Human | >98% | E. coli | 20 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| H00008861-Q01-10 | LDB1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008861-Q01-25 | LDB1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009079-P01-10 | LDB2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009079-P01-25 | LDB2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| Items 1 to 100 of 496 total | 5 Page(s): |


